Toy Andrew, the Chief Executive Officer of Clover Health Investments, has sold 62,176 shares of Class A Common Stock to meet tax withholding obligations. This transaction, reported in a recent SEC filing, is significant as it underscores the financial management practices of executives within the health services sector.
The sale occurred on October 15, 2026, and was necessitated by the quarterly vesting of restricted stock units that were originally granted to Andrew on October 15, 2024. According to the filing, the shares were sold at a weighted average price of $4.68, with the sales mandated by the company's election under its equity incentive plans.
Background
Clover Health Investments, which operates under the ticker symbol CLOV, is a company involved in providing hospital and medical service plans. The firm was previously known as Clover Health Investments, Corp. and has undergone name changes in the past. The company is based in Jersey City, New Jersey, and is incorporated in Delaware.
What the Filing Says
The SEC filing indicates that the shares sold were part of a required transaction to cover tax withholding obligations related to the vesting of restricted stock units. The filing states, "These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person." This clarifies that the sale was not a personal investment decision but rather a compliance measure.
Impact
This transaction may affect various stakeholders, including shareholders and employees who are part of Clover Health's equity incentive plans. The sale reflects broader trends in executive compensation within the health services industry, where companies are increasingly tying compensation to stock performance and tax obligations.
What's Next
The filing does not say what happens next regarding Andrew's future stock transactions or any potential changes in his role at Clover Health. However, the continued vesting of restricted stock units suggests that more transactions may occur as part of the company's compensation strategy.